Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 8028257
[patent_doc_number] => 08143210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Enzyme treatment of foodstuffs for celiac sprue'
[patent_app_type] => utility
[patent_app_number] => 11/775824
[patent_app_country] => US
[patent_app_date] => 2007-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 29683
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143210.pdf
[firstpage_image] =>[orig_patent_app_number] => 11775824
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/775824 | Enzyme treatment of foodstuffs for celiac sprue | Jul 9, 2007 | Issued |
Array
(
[id] => 4927888
[patent_doc_number] => 20080167251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'Angiotensin-(1-7) and Angiotensin-(1-7) Agonists for Inhibition of Cancer Cell Growth'
[patent_app_type] => utility
[patent_app_number] => 11/769506
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 14903
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167251.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769506
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769506 | Angiotensin-(1-7) and angiotensin-(1-7) agonists for inhibition of cancer cell growth | Jun 26, 2007 | Issued |
Array
(
[id] => 9323740
[patent_doc_number] => 08658763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-25
[patent_title] => 'Amphiphilic peptides and hydrogel matrices thereof for bone repair'
[patent_app_type] => utility
[patent_app_number] => 12/305588
[patent_app_country] => US
[patent_app_date] => 2007-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 17290
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12305588
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305588 | Amphiphilic peptides and hydrogel matrices thereof for bone repair | Jun 18, 2007 | Issued |
Array
(
[id] => 4765579
[patent_doc_number] => 20080176791
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-24
[patent_title] => 'NOVEL ALBUMIN-FREE FACTOR VIII FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/764770
[patent_app_country] => US
[patent_app_date] => 2007-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7432
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0176/20080176791.pdf
[firstpage_image] =>[orig_patent_app_number] => 11764770
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/764770 | Albumin-free factor VIII formulations | Jun 17, 2007 | Issued |
Array
(
[id] => 4451232
[patent_doc_number] => 07964556
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-06-21
[patent_title] => 'Antimicrobial peptides and use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/761869
[patent_app_country] => US
[patent_app_date] => 2007-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11658
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964556.pdf
[firstpage_image] =>[orig_patent_app_number] => 11761869
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/761869 | Antimicrobial peptides and use thereof | Jun 11, 2007 | Issued |
Array
(
[id] => 5126485
[patent_doc_number] => 20070238756
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-10-11
[patent_title] => 'COMBINATIONS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AND OTHER ANTIDIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS'
[patent_app_type] => utility
[patent_app_number] => 11/758259
[patent_app_country] => US
[patent_app_date] => 2007-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4440
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0238/20070238756.pdf
[firstpage_image] =>[orig_patent_app_number] => 11758259
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/758259 | COMBINATIONS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AND OTHER ANTIDIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS | Jun 4, 2007 | Abandoned |
Array
(
[id] => 4670420
[patent_doc_number] => 20080045480
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'Inhibitors of serine proteases, particularly HCV NS3-NS4A protease'
[patent_app_type] => utility
[patent_app_number] => 11/805085
[patent_app_country] => US
[patent_app_date] => 2007-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17951
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045480.pdf
[firstpage_image] =>[orig_patent_app_number] => 11805085
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/805085 | Inhibitors of serine proteases, particularly HCV NS3-NS4A protease | May 21, 2007 | Issued |
Array
(
[id] => 4693245
[patent_doc_number] => 20080086016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-10
[patent_title] => 'ABUSE RESISTANT LYSINE AMPHETAMINE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 11/745019
[patent_app_country] => US
[patent_app_date] => 2007-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 55
[patent_no_of_words] => 26281
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20080086016.pdf
[firstpage_image] =>[orig_patent_app_number] => 11745019
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/745019 | Abuse resistant lysine amphetamine compounds | May 6, 2007 | Issued |
Array
(
[id] => 4965747
[patent_doc_number] => 20080108567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'Leptin-related peptides'
[patent_app_type] => utility
[patent_app_number] => 11/789762
[patent_app_country] => US
[patent_app_date] => 2007-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 38641
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108567.pdf
[firstpage_image] =>[orig_patent_app_number] => 11789762
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/789762 | Leptin-related peptides | Apr 23, 2007 | Issued |
Array
(
[id] => 8664611
[patent_doc_number] => 08378072
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-19
[patent_title] => 'Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability'
[patent_app_type] => utility
[patent_app_number] => 11/787229
[patent_app_country] => US
[patent_app_date] => 2007-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 23629
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 372
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11787229
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/787229 | Methods for designing and synthesizing directed sequence polymer compositions via the directed expansion of epitope permeability | Apr 12, 2007 | Issued |
Array
(
[id] => 5130765
[patent_doc_number] => 20070207162
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system'
[patent_app_type] => utility
[patent_app_number] => 11/783678
[patent_app_country] => US
[patent_app_date] => 2007-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 12027
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207162.pdf
[firstpage_image] =>[orig_patent_app_number] => 11783678
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/783678 | Ubiquitin and ubiquitin related molecules for treatment and prevention of harmful activation of the immune system | Apr 10, 2007 | Abandoned |
Array
(
[id] => 6492468
[patent_doc_number] => 20100093614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'Novel Composition for Tumor Growth Control'
[patent_app_type] => utility
[patent_app_number] => 12/225842
[patent_app_country] => US
[patent_app_date] => 2007-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6529
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093614.pdf
[firstpage_image] =>[orig_patent_app_number] => 12225842
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/225842 | Novel Composition for Tumor Growth Control | Apr 1, 2007 | Abandoned |
Array
(
[id] => 5177112
[patent_doc_number] => 20070178172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-08-02
[patent_title] => 'Composition for reducing blood lipids'
[patent_app_type] => utility
[patent_app_number] => 11/730231
[patent_app_country] => US
[patent_app_date] => 2007-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2018
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0178/20070178172.pdf
[firstpage_image] =>[orig_patent_app_number] => 11730231
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/730231 | Composition for reducing blood lipids | Mar 29, 2007 | Abandoned |
Array
(
[id] => 5189064
[patent_doc_number] => 20070167373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Combined use of a GLP-1 compound and a modulator of diabetic late complications'
[patent_app_type] => utility
[patent_app_number] => 11/726690
[patent_app_country] => US
[patent_app_date] => 2007-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6453
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167373.pdf
[firstpage_image] =>[orig_patent_app_number] => 11726690
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/726690 | Combined use of a GLP-1 compound and a modulator of diabetic late complications | Mar 21, 2007 | Abandoned |
Array
(
[id] => 5159848
[patent_doc_number] => 20070172892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-26
[patent_title] => 'NOVEL POLYPEPTIDE ESDN, POLYNUCLEOTIDES ENCODING THE POLYPEPTIDE, AND UTILITY OF THE POLYPEPTIDE'
[patent_app_type] => utility
[patent_app_number] => 11/688170
[patent_app_country] => US
[patent_app_date] => 2007-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8258
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20070172892.pdf
[firstpage_image] =>[orig_patent_app_number] => 11688170
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/688170 | Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide | Mar 18, 2007 | Issued |
Array
(
[id] => 5189043
[patent_doc_number] => 20070167352
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-19
[patent_title] => 'Methods and compositions for oxygen transport comprising a method for making a high oxygen affinity modified hemoglobin'
[patent_app_type] => utility
[patent_app_number] => 11/717364
[patent_app_country] => US
[patent_app_date] => 2007-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12500
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20070167352.pdf
[firstpage_image] =>[orig_patent_app_number] => 11717364
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/717364 | Method for making a high oxygen affinity modified hemoglobin for oxygen transport | Mar 12, 2007 | Issued |
Array
(
[id] => 5220261
[patent_doc_number] => 20070161572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-07-12
[patent_title] => 'Drug therapy for Celiac Sprue'
[patent_app_type] => utility
[patent_app_number] => 11/713353
[patent_app_country] => US
[patent_app_date] => 2007-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 118928
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0161/20070161572.pdf
[firstpage_image] =>[orig_patent_app_number] => 11713353
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/713353 | Drug therapy for Celiac Sprue | Mar 1, 2007 | Abandoned |
Array
(
[id] => 32693
[patent_doc_number] => 07790686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-07
[patent_title] => 'Injection solution of an LHRH antagonist'
[patent_app_type] => utility
[patent_app_number] => 11/711235
[patent_app_country] => US
[patent_app_date] => 2007-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1277
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/790/07790686.pdf
[firstpage_image] =>[orig_patent_app_number] => 11711235
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/711235 | Injection solution of an LHRH antagonist | Feb 26, 2007 | Issued |
Array
(
[id] => 5368434
[patent_doc_number] => 20090305993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'METHODS AND COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/280376
[patent_app_country] => US
[patent_app_date] => 2007-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 356
[patent_figures_cnt] => 356
[patent_no_of_words] => 118656
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0305/20090305993.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280376
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280376 | METHODS AND COMPOSITION FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS | Feb 25, 2007 | Abandoned |
Array
(
[id] => 6417236
[patent_doc_number] => 20100167261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-01
[patent_title] => 'PLATELET STABILIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/280027
[patent_app_country] => US
[patent_app_date] => 2007-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9809
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20100167261.pdf
[firstpage_image] =>[orig_patent_app_number] => 12280027
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/280027 | PLATELET STABILIZATION | Feb 19, 2007 | Abandoned |